TransMedics Group, Inc. (TMDX) Cash Flow Statement
TransMedics Group, Inc. (TMDX) generated $145.9M of operating cash flow over the twelve months to 2026-06-30, spent $66.9M on capital expenditure and had free cash flow of $79.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMDXTransMedics Group, Inc.Follow TMDX — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.03 | -0.03 | -0.03 | -0.05 | -0.01 | 0.05 | 0.19 | 0.15 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.01 | 0.15 | 0.13 | 0.06 | -0.07 | |
| Free cash flow | -0.03 | -0.03 | -0.03 | -0.06 | -0.16 | -0.08 | 0.13 | 0.08 | |
| Stock-based compensation | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | — |
USD billions · SEC XBRL
TransMedics Group, Inc. — questions
- What is TransMedics Group, Inc.'s operating cash flow?
- $145.9M over the twelve months to 2026-06-30.
- How much does TransMedics Group, Inc. spend on capital expenditure?
- $66.9M over the twelve months to 2026-06-30.
- What is TransMedics Group, Inc.'s free cash flow?
- $79.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from TransMedics Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.